Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (51-60 of 802) with videos related to

Pageof 81
Sort By:
Respiration; International Review of Thoracic Diseases|March 9, 2005
Novel approaches to the treatment of bacterial lower respiratory tract infections: introductionMario Cazzola, Cesare Saltini
Haematologica|November 9, 2004
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drugFrancesco Passamonti, Mario Cazzola
British Journal of Haematology|July 9, 2016
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblastsLuca Malcovati, Mario Cazzola
Handbook of Experimental Pharmacology|October 28, 2016
Bifunctional Drugs for the Treatment of Respiratory DiseasesClive Page, Mario Cazzola
Respiratory Medicine|May 4, 2023
There is still no established and accepted definition of COPDMario Cazzola, Francesco Blasi
Haematologica|May 6, 2010
Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationshipMario Cazzola, Rosangela Invernizzi
The European Respiratory Journal|November 3, 2018
An inhaled "bifunctional" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPDMario Cazzola, Clive Page
The New England Journal of Medicine|March 21, 2014
JAK inhibitor in CALR-mutant myelofibrosisMario Cazzola, Robert Kralovics
The New England Journal of Medicine|February 11, 2005
Myelodysplastic syndromes--coping with ineffective hematopoiesisMario Cazzola, Luca Malcovati
Polskie Archiwum Medycyny Wewnetrznej|March 28, 2008
How to prevent relapse after acute exacerbation of asthma?Mario Cazzola, Giacomo Curradi
Pageof 81

Showing results (51-60 of 802) with videos related to

Sort By:
Pageof 81
Respiration; International Review of Thoracic Diseases|March 9, 2005
Novel approaches to the treatment of bacterial lower respiratory tract infections: introductionMario Cazzola, Cesare Saltini
Haematologica|November 9, 2004
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drugFrancesco Passamonti, Mario Cazzola
British Journal of Haematology|July 9, 2016
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblastsLuca Malcovati, Mario Cazzola
Handbook of Experimental Pharmacology|October 28, 2016
Bifunctional Drugs for the Treatment of Respiratory DiseasesClive Page, Mario Cazzola
Respiratory Medicine|May 4, 2023
There is still no established and accepted definition of COPDMario Cazzola, Francesco Blasi
Haematologica|May 6, 2010
Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationshipMario Cazzola, Rosangela Invernizzi
The European Respiratory Journal|November 3, 2018
An inhaled "bifunctional" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPDMario Cazzola, Clive Page
The New England Journal of Medicine|March 21, 2014
JAK inhibitor in CALR-mutant myelofibrosisMario Cazzola, Robert Kralovics
The New England Journal of Medicine|February 11, 2005
Myelodysplastic syndromes--coping with ineffective hematopoiesisMario Cazzola, Luca Malcovati
Polskie Archiwum Medycyny Wewnetrznej|March 28, 2008
How to prevent relapse after acute exacerbation of asthma?Mario Cazzola, Giacomo Curradi
Pageof 81